KDMN · Kadmon Corporation
Acquired Company
Sanofi completed the acquisition of Kadmon Holdings, Inc. on November 9, 2021 for approximately US $1.9 billion in cash.
Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Its clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.
450 E 29th St, New York, 10016-8367, US
Pharmaceutical Preparation Manufacturing
Manufacturing
Market Cap
N/A
52 Wk Range
N/A - N/A
Previous Close
$9.50
Open
$9.50
Volume
1,052
Day Range
$9.50 - $9.50
Enterprise Value
N/A
Cash
N/A
Avg Qtr Burn
N/A
Insider Ownership
N/A
Institutional Own.
N/A
Qtr Updated
Mar 31st 2024